[11C]JNJ-42491293

JNJ-42491293 · Johnson & Johnson Pharmaceutical Research and Development, L.L.C.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [11C]JNJ-42491293, covering 2011-07-22 to 2011-07-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of [11C]JNJ-42491293, a Possible PET Ligand for the mGlu2 Receptor, in Healthy Adult Volunteers [Phase 1]